Addition and Subtraction Theory of TCM Using Xiao-Chaihu-Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study
- PMID: 27843477
- PMCID: PMC5098078
- DOI: 10.1155/2016/4723530
Addition and Subtraction Theory of TCM Using Xiao-Chaihu-Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study
Abstract
To investigate the therapeutic effect of combined Xiao-Chaihu-Decoction and naturopathic medicine therapy on survival outcomes of patients' PLC. In XCHD group (n = 76), patients were treated with Xiao-Chaihu-Decoction in accordance with the addition and subtraction theory of TCM; in NM group (n = 89), patients were managed by naturopathic medicine; in combined group (n = 70), the same volume of Xiao-Chaihu-Decoction combined with naturopathic medicine procedures was applied. There were no evident statistical differences of age, gender, KPS score, body weight, smoking status, AFP levels, HbsAg status, TBIL levels, tumor diameters, and numbers among different groups, showing comparability among groups. No significant difference was found regarding the total remission rate and stability rate of tumors in patients treated by Xiao-Chaihu-Decoction and naturopathic medicine, except the combined therapy. KPS scores were significantly improved after treatment among groups. After treatment, 52.8% cases maintained a stable or slight increase in weight, of which 42.1%, 48.3%, and 70.0% cases maintained weight stably in the XCHD group, NM group, and combined treatment group, respectively. Xiao-Chaihu-Decoction associated with naturopathy may predict improved prognostic outcomes in PLC patients, along with improved remission and stability rates, increased KPS scores, and stable weight maintenance.
Figures

Similar articles
-
Systems pharmacology-based approach for dissecting the addition and subtraction theory of traditional Chinese medicine: An example using Xiao-Chaihu-Decoction and Da-Chaihu-Decoction.Comput Biol Med. 2014 Oct;53:19-29. doi: 10.1016/j.compbiomed.2014.05.007. Epub 2014 May 28. Comput Biol Med. 2014. PMID: 25105750
-
[Connotation of Xiao Chaihu Decoction combined with Maxing Shigan Decoction based on severe cases and modern pathophysiological mechanism and application for severe pulmonary infection and acute exacerbation of chronic obstructive pulmonary disease in critical care medicine].Zhongguo Zhong Yao Za Zhi. 2023 May;48(10):2606-2612. doi: 10.19540/j.cnki.cjcmm.20230215.501. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37282920 Chinese.
-
[Chaihu Longgu Muli decoction combined with acupuncture at back-shu points for chronic fatigue syndrome].Zhongguo Zhen Jiu. 2017 Nov 12;37(11):1187-90. doi: 10.13703/j.0255-2930.2017.11.013. Zhongguo Zhen Jiu. 2017. PMID: 29354956 Clinical Trial. Chinese.
-
Prescription of Chinese Herbal Medicine in Pattern-Based Traditional Chinese Medicine Treatment for Depression: A Systematic Review.Evid Based Complement Alternat Med. 2015;2015:160189. doi: 10.1155/2015/160189. Epub 2015 Jun 9. Evid Based Complement Alternat Med. 2015. PMID: 26180532 Free PMC article. Review.
-
Naturopathy.Med Clin North Am. 2002 Jan;86(1):173-84. doi: 10.1016/s0025-7125(03)00079-8. Med Clin North Am. 2002. PMID: 11795088 Review.
Cited by
-
Unveiling the therapeutic role of Dachaihu decoction in acute cholecystitis: a comprehensive systematic review and meta-analysis of its efficacy and safety.Front Pharmacol. 2024 Nov 27;15:1497072. doi: 10.3389/fphar.2024.1497072. eCollection 2024. Front Pharmacol. 2024. PMID: 39664516 Free PMC article.
-
What Do Primary Healthcare Providers and Complementary and Alternative Medicine Practitioners in Palestine Need to Know about Exercise for Cancer Patients and Survivors: A Consensual Study Using the Delphi Technique.Evid Based Complement Alternat Med. 2019 Apr 17;2019:7695818. doi: 10.1155/2019/7695818. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31118968 Free PMC article.
-
Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4.Cancer Biol Ther. 2023 Dec 31;24(1):2246198. doi: 10.1080/15384047.2023.2246198. Epub 2023 Sep 29. Cancer Biol Ther. 2023. PMID: 37773732 Free PMC article.
-
Sixteen prescribed Chinese herbal medicines provide time-dependent cardiorenal and survival benefits in patients with overall and advanced diabetic kidney disease: a real-world study in Taiwan.Front Pharmacol. 2024 Aug 22;15:1297854. doi: 10.3389/fphar.2024.1297854. eCollection 2024. Front Pharmacol. 2024. PMID: 39239654 Free PMC article.
References
-
- Cheng A.-L., Guan Z., Chen Z., et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial. European Journal of Cancer. 2012;48(10):1452–1465. doi: 10.1016/j.ejca.2011.12.006. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources